Foot Problems in Lupus: Vasculitis, Arthritis, and Skin Changes

Medically reviewed by Dr. Tom Biernacki, DPM — Board-Certified Podiatric Surgeon — Balance Foot & Ankle, Howell & Bloomfield Hills, MI. Last updated April 2026.

▶ Watch

Lupus and the Foot: Multisystem Effects

Systemic lupus erythematosus (SLE) — the prototypical autoimmune disease — affects the feet through multiple pathways: joint inflammation (arthritis), vascular involvement (vasculitis, Raynaud’s phenomenon, antiphospholipid syndrome-related ischemia), skin manifestations, and the complications of long-term immunosuppressive treatment. Understanding these distinct mechanisms allows podiatrists to address each appropriately in collaboration with rheumatology. At Balance Foot & Ankle in Howell and Bloomfield Township, Michigan, we provide foot care for lupus patients with awareness of the systemic complexity these patients represent.

Lupus Arthritis of the Foot

Arthritis occurs in 90% of patients with SLE and is one of the most common presenting features. Unlike rheumatoid arthritis, lupus arthritis is typically non-erosive — it doesn’t cause the bone erosion and destruction that RA produces at the joint margins. Lupus arthritis is often migratory (moving between joints) and may involve the ankle, subtalar, and MTP joints. The non-erosive character means joint deformity is less severe than in RA, but pain and functional limitation can still be significant. Management: footwear modification, orthotics, and carefully selected analgesics with awareness of NSAIDs’ potential to cause lupus flare or nephritis complications.

Vascular Foot Manifestations

Lupus-related vascular problems create several foot concerns. Raynaud’s phenomenon: episodic digital vasospasm causing color change (white to blue to red) from cold or stress exposure — occurs in 30-50% of lupus patients and is generally more severe than primary Raynaud’s. Lupus patients with Raynaud’s should avoid cold exposure, use chemical toe warmers for outdoor winter activity in Michigan, and discuss vasodilator therapy with rheumatology for severe cases. Antiphospholipid syndrome (APS): present in 30-40% of SLE patients, APS causes hypercoagulability with risk of arterial and venous thrombosis — foot and lower leg arterial occlusion can cause ischemic toes and ulcers. Any SLE patient with a history of thrombosis or livedo reticularis (a mottled skin pattern) who develops foot pain or color changes warrants urgent vascular assessment.

Medication Side Effects Affecting Feet

Long-term lupus treatments have foot-relevant side effects. Corticosteroids: chronic use causes osteoporosis (increasing stress fracture risk), avascular necrosis (which can rarely affect the talus), and heel fat pad thinning. Hydroxychloroquine (Plaquenil): a well-tolerated DMARD without significant foot-specific side effects but requires regular ophthalmology monitoring. Immunosuppressants (azathioprine, mycophenolate): reduce infection resistance — minor foot infections or skin breaks require prompt attention as they can escalate. Contact Balance Foot & Ankle at (810) 206-1402 for foot care that integrates with your rheumatologic management of lupus.

Foot or Ankle Pain? We Can Help.

Balance Foot & Ankle — Howell & Bloomfield Township, MI

📅 Book Online
📞 (810) 206-1402

When to See a Podiatrist for Lupus Foot Problems

Lupus can cause painful vasculitis, arthritis, and skin changes in the feet that require specialized care. At Balance Foot & Ankle, Dr. Tom Biernacki manages autoimmune-related foot conditions including Raynaud phenomenon, joint inflammation, digital ulcers, and custom orthotic fitting for arthritic joints.

Learn About Our Specialized Foot Care Services | Book Your Appointment | Call (810) 206-1402

Clinical References

1. Otter SJ, Kumar S, Gow P, et al. Patterns of foot complaints in systemic lupus erythematosus: a cross sectional survey. J Foot Ankle Res. 2010;3:19.
2. Williams AE, Croft AP, Sherrington A, et al. Foot and ankle characteristics associated with body of evidence in systemic lupus erythematosus. Lupus. 2018;27(14):2234-2241.
3. Cervera R, Khamashta MA, Font J, et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine. 2003;82(5):299-308.

Your Board-Certified Podiatrists

Dr. Tom Biernacki, DPM

Board-Certified · FACFAS

Dr. Carl Jay, DPM

Board-Certified Podiatrist

Dr. Daria Gutkin, DPM

Podiatrist

Dr. Tom Biernacki, DPM

Affiliate Disclosure: This page contains affiliate links to products we recommend. If you purchase through these links, Balance Foot & Ankle may earn a small commission at no additional cost to you. We only recommend products we use with our patients.

Dr. Tom Biernacki, DPM is a double board-certified podiatrist and foot & ankle surgeon at Balance Foot & Ankle Specialists in Southeast Michigan. With over a decade of clinical experience, he specializes in heel pain, bunions, diabetic foot care, sports injuries, and minimally invasive surgery. Dr. Biernacki is a member of the APMA and ACFAS, and his patient education content on MichiganFootDoctors.com and YouTube has reached over one million views.